Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added related topic tags for Melanoma and MedlinePlus Genetics. These additions connect the study page with broader melanoma-related and genetics resources, providing quick access to contextual materials.
    Difference
    0.2%
    Check dated 2026-06-22T11:22:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now indicates that the study is no longer recruiting participants and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention / Treatment label was updated to Intervention/Treatment and the site revision is updated to v3.6.0 from v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-15T08:31:10.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.5 and certain unrelated topics (e.g., Melanoma and MedlinePlus Genetics) were removed from the related topics, reflecting metadata cleanup rather than a change to study details.
    Difference
    0.2%
    Check dated 2026-06-08T05:50:48.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now includes Melanoma as a related topic and adds a MedlinePlus Genetics section under related topics. These additions provide quick access to melanoma-related information and genetics resources without changing the study details.
    Difference
    0.2%
    Check dated 2026-05-25T06:26:12.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now shown on the page, replacing the previous Revision: v3.5.3. This change represents an update to the site's deployment version rather than study-related content.
    Difference
    0.1%
    Check dated 2026-05-18T03:47:34.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Deletes the Melanoma disease reference and the related topics header and MedlinePlus Genetics link from the page. This changes how readers interpret the study focus and locate related background resources.
    Difference
    0.2%
    Check dated 2026-05-11T01:31:21.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.